Group 1: Economic Policies and Developments - The State Council, led by Premier Li Qiang, emphasized the need to advance the silver economy and elderly care services, highlighting the potential for growth and the importance of policy support to address aging population challenges [2] - The Ministry of Commerce expressed China's willingness to engage in candid discussions during the upcoming sixth round of China-U.S. economic and trade consultations, while closely monitoring U.S. tariff adjustments [2] - The People's Bank of China announced a 600 billion yuan MLF operation with a one-year term to maintain ample liquidity in the banking system [2] Group 2: Market and Economic Indicators - During the 2026 Spring Festival holiday, domestic travel reached 596 million trips, generating a total expenditure of 803.48 billion yuan, marking a historical high in both visitor numbers and spending [2] - The average price of gasoline and diesel in China increased by 175 yuan and 170 yuan per ton, respectively, effective from February 24, due to rising international oil prices [2] - The light rare earth price index rose by 12.67% to 2090 points, driven by active replenishment by downstream enterprises and tight raw material supply [2] Group 3: Corporate Announcements - Semiconductor company Shenghe Jingwei's IPO application was approved, aiming to raise 4.8 billion yuan for multi-chip integration packaging projects [2] - Dazhu Laser plans to establish an overseas operation center in Southeast Asia with an investment of 150 million USD [7] - Huaneng Water Power's restructuring fund intends to increase its stake in the company by 100 to 150 million yuan [7]

Company News - Dongyangguang announced plans to acquire control of Yichang Dongshu No. 1 Investment Co., Ltd. through a share issuance and raise matching funds, which is expected to constitute a major asset restructuring and related party transaction. The company's stock has been suspended since February 24, with a maximum suspension period of 10 trading days [3] - Capcloud decided to terminate its major asset restructuring plan to acquire 70% and 30% stakes in Nanning Taike from Shenzhen Jintaike due to failure to reach consensus on core transaction terms amid changing market conditions. The board approved this decision on February 24 [3][4] - Capcloud plans to repurchase shares with a total amount not less than 50 million yuan and not exceeding 100 million yuan, with a maximum repurchase price of 315 yuan per share. The repurchase is expected to cover 158,730 to 317,460 shares, accounting for 0.23% to 0.47% of the total share capital [4] - Sanofi Guojian reported a revenue of 4.199 billion yuan for 2025, a year-on-year increase of 251.81%, and a net profit attributable to shareholders of 2.939 billion yuan, up 317.09%. The company received a significant upfront payment from Pfizer for a project, contributing approximately 2.89 billion yuan to its revenue [5] - Zhongke Shuguang reported a revenue of 14.97 billion yuan for 2025, a year-on-year increase of 13.86%, and a net profit attributable to shareholders of 2.113 billion yuan, up 10.54%. The company improved its product structure and operational efficiency to achieve this growth [6] - Zhongwei Semiconductor reported a revenue of 1.122 billion yuan for 2025, a year-on-year increase of 23.09%, and a net profit attributable to shareholders of 285 million yuan, up 108.05%. The growth was driven by increased shipments of automotive-grade chips and industrial control chips [6] - Conch Cement announced plans to increase its A-share holdings with a total investment of not less than 700 million yuan and not exceeding 1.4 billion yuan over the next six months, reflecting confidence in the company's long-term investment value [6] - Tongwei Co. is planning to acquire 100% of Qinghai Lihua Qingneng Co., Ltd. through a combination of share issuance and cash payment, with stock and convertible bonds suspended from trading starting February 25 for a maximum of 10 trading days. This transaction is not expected to change the controlling shareholder [7] - Yushu Technology launched a new quadruped robot, Unitree As2, which boasts double the power performance of its predecessor, Go2, with a no-load endurance of over 4 hours and a 15 kg load endurance of over 13 km [7] Industry News - The State Council meeting on February 24 emphasized the potential of the silver economy and the need to enhance support measures for the elderly care industry, aiming to stimulate consumption demand and create new consumption scenarios for the elderly [2] - The People's Bank of China announced the latest Loan Prime Rate (LPR) on February 24, with the 1-year rate remaining at 3.0% and the 5-year rate at 3.5%, unchanged from the previous period [2]

Group 1 - The article discusses three ETFs launched by E Fund that track different indices of the ChiNext market, focusing on low fees and specific sector compositions [2] - The ChiNext Index ETF tracks 100 stocks with large market capitalization and good liquidity, with nearly 60% of its composition in emerging industries such as power equipment, communication, and electronics [2] - The ChiNext 200 ETF tracks 200 mid-cap stocks, reflecting the overall performance of mid-cap companies in the ChiNext market, with over 40% of its composition in the information technology sector [2] - The ChiNext Growth ETF tracks 50 stocks characterized by growth potential and good liquidity, with approximately 85% of its composition in sectors like communication, power equipment, electronics, computers, and biomedicine [2] Group 2 - The rolling price-to-earnings (P/E) ratio for the ChiNext Index ETF is 42.1 times, while the ChiNext 200 ETF has a P/E ratio of 113.0 times, and the ChiNext Growth ETF has a P/E ratio of 40.7 times [2] - The performance of these ETFs since their launch shows varying growth rates, with the ChiNext Index ETF increasing by 1.0%, the ChiNext 200 ETF by 0.4%, and the ChiNext Growth ETF by 1.5% [2]

Market Overview - The Hang Seng Index decreased by 491.59 points, or 1.82%, closing at 26,590.32 [1] - The Hang Seng Technology Index fell by 114.65 points, or 2.13%, while the Hang Seng Biotechnology Index dropped by 541.42 points, or 3.34% [1] Technology Sector - Internet technology stocks collectively declined, with Alibaba down by 2.7%, Kingsoft Cloud down by 5%, and Kuaishou and Xiaomi both falling over 2% [1] - Tencent Music saw a drop of 5.62%, closing at 57.10, while Meituan fell by 4.24% to 81.40 [2] - Tencent Holdings decreased by 3.35%, closing at 520.00 [2] Pharmaceutical Sector - The pharmaceutical sector weakened, with notable declines including Tigermed down over 3.6% and Zai Lab down 7.3% [2] - Other companies like WuXi AppTec, Innovent Biologics, and Alibaba Health also reported losses [2][3] - Three-Sixty Pharmaceuticals fell by 6.69%, closing at 22.30, while China Biologic Products dropped by 6.58% to 6.39 [3] Consumer Sector - The consumer discretionary sector experienced a downturn, highlighted by China Duty Free Group falling over 10% [4] - China Duty Free Group closed at 82.20, down 10.51% [4] AI Sector - The AI application sector showed activity, with Zhiyun rising over 12% and accumulating a 177% increase this month [4][5] - MINIMAX-WP increased by 4.70%, closing at 880.00, while Zhiyun reached 628.00, up 12.14% [5] - The latest Hugging Face open-source model rankings featured eight models from Chinese teams, including those from Alibaba and Zhiyun [5] Oil Market - International crude oil futures rose, with Shandong Molong increasing over 11% and accumulating a nearly 45% rise this year [5] - WTI crude futures for March rose by 1.9%, while Brent crude futures for April increased by 1.86% [5]

作者 | 市值风云基金研究部 编辑 | 小白 从业1 4 年，规模加权任职回报高达1 2.7% "十倍股捕手、最早赛道股基金经理"是杜猛给市场的印象，那当下这轮牛市，杜猛抓到了没有？ 加仓锂电、有色、化工，紧扣涨价逻辑。 （来源：市值风云APP研报） 杜猛，基金经理从业年限14.6年，现任基金资产总规模180亿，在管基金最佳任职回报高达828.9%， 任职以来年化（规模加权）为12.7%，成绩依然能打。 拉长时间看，杜猛确实是牛市中的干将，在最近两次牛市中，其基金净值表现尤为突出，但在熊市阶 段，其业绩相对跑输市场。可见，他在牛市中的操作思路和布局策略，具有一定的参考价值。 （来源：天天基金网） 杜猛在任4只基金，任职回报全部收正，摩根新兴动力混合（A：377240.OF；C：014642.OF）是其代 表作，去年四季度末合并规模为110.4亿，环比小幅增长14亿。 | | | | 杜猛管理过的基金一览 | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | | 基金代码 | 基金名称 | 育等来到 | 规模(亿元) | 任职时间 | 任职天 ...

Core Viewpoint - The technology sector is expected to lead the market, with a focus on technology and cyclical stocks, driven by recent catalysts in the domestic technology industry during the Spring Festival [1] Group 1: Market Performance - The Guotai Science and Innovation ETF (588360) rose over 1.1% on February 24, indicating positive market sentiment towards technology stocks [1] - The Science and Innovation 50 Index (931643), which the ETF tracks, includes 50 large-cap emerging industry companies, reflecting the overall performance of representative emerging industries [1] Group 2: Industry Trends - The acceptance of AI among residents is increasing, with the proliferation and application of domestic large AI models suggesting a potential for China to achieve a competitive edge in AI [1] - Four robotics companies showcased their products during the Spring Festival Gala, highlighting China's advantages in humanoid robotics, including cluster control, hardware manufacturing, and mass production capabilities [1] Group 3: Investment Focus - The current investment strategy should focus on sectors such as computing hardware, AI applications, robotics, intelligent driving, and energy storage, which are expected to benefit from industry catalysts [1] - The technology sector is anticipated to continue unlocking valuation limits under the Kondratiev wave cycle, with robotics and AI-related industries likely to respond first to market changes [1]

Core Viewpoint - The Chinese capital market is poised for significant growth driven by reforms and innovations, with a focus on technology independence and industrial upgrades as part of the national strategy, creating a historical opportunity for growth-oriented innovative companies [1] Group 1: Market Trends - Hard technology sectors such as artificial intelligence, high-end chips, and commercial aerospace are gaining unprecedented attention, providing a solid growth foundation for the capital market [2] - As traditional economic risks diminish and new growth drivers emerge, corporate profitability is expected to enter a recovery phase [2] - The "14th Five-Year Plan" emphasizes technology industries, consumer spending, and the construction of a unified national market, continuously catalyzing growth sectors [2] Group 2: Index Fund Advantages - Index investing has become increasingly popular due to its clear rules, transparency, and low costs, serving as an important tool for asset allocation and capturing market beta returns [3] - The components of the ChiNext 50 Index are concentrated in strategic emerging sectors such as power equipment, communications, electronics, and biomedicine, with the top three industries accounting for approximately 72% [3] - Since its base date on May 31, 2010, the ChiNext 50 Index has cumulatively increased by 238.58%, demonstrating strong long-term returns and significant elastic gains [3] - The ChiNext 50 Index components exhibit strong profitability resilience and growth potential due to technological barriers and innovative business models [3] Group 3: Fund Issuance - The issuance of the Bank of China ChiNext 50 Index Fund provides investors with a convenient way to participate in the growth of innovative companies, acting as a bridge to share in China's innovation and growth future [4]

Market Overview - The Hang Seng Index is expected to hold at 26,000 points, influenced by the hawkish stance of the newly appointed Federal Reserve Chair and a rebound in the US dollar index, which has led to profit-taking in the commodity market [2] - The Chinese GDP growth target for 2026 is anticipated to be set at 4.5%-5%, lower than the previous target of around 5% for 2025, as many provinces have lowered their GDP goals ahead of the Two Sessions [2] - Regulatory measures have been implemented to cool the market, including increased financing margin ratios on the Shanghai and Shenzhen stock exchanges, leading to a collective reduction in leverage across the three markets [2] Sector Focus - AI stocks are expected to perform well due to intensive upgrades in AI large models and rapid growth in the semiconductor industry [3] Corporate News - Estun (002747.SZ), a company specializing in industrial robots, has passed the Hong Kong Stock Exchange listing hearing, targeting high-end industrial equipment markets [10] - Alibaba's Qianwen App facilitated nearly 200 million "one-sentence orders" during the Spring Festival, indicating a significant increase in user engagement [10] - Ant Group reported that its "AI Payment" and Ant Assistant App have both surpassed 100 million users, marking a significant milestone in AI-driven payment solutions [10] - JD Group reported a fourfold increase in user visits to its robot products during the Spring Festival, highlighting a growing interest in robotics and AI-related products [8][10] Economic Indicators - The Hang Seng Index closed at 27,081 points, up 668 points or 2.5%, with a total market turnover of HKD 173 billion [6] - The CRB Commodity Index decreased by 0.28% year-to-date, while gold prices increased by 2.35% [5] - The vacancy rate for Grade A offices in Central Hong Kong fell to 10.1%, the lowest level since 2023, indicating a recovery in leasing demand driven by financial institutions [8][10]

Company News - Tongguan Gold (00340.HK) expects a net profit of approximately HKD 820 million to HKD 840 million in 2025, representing a year-on-year increase of about 289% to 298%, mainly due to increased production and sales of gold and higher average selling prices [1] - China State Construction Industry (00830.HK) anticipates a net profit of approximately HKD 237 million for the fiscal year 2025, down from HKD 650 million in the previous year, primarily due to a decrease in new project volume and revenue [1] - Kintor Group (00148.HK) projects a net profit growth of over 165% in 2025, exceeding HKD 4.32 billion, driven by growth in investment business and profits from copper-clad laminates [1] - Kintor Laminates (01888.HK) expects a net profit increase of over 80% in 2025, exceeding HKD 2.39 billion, attributed to strong demand for copper-clad laminates and upstream materials including fiberglass yarn, fiberglass cloth, and copper foil [1] - China Starch (03838.HK) forecasts total revenue of RMB 10.058 billion in 2025, with a pre-tax profit of RMB 838 million, a significant decrease of approximately 64% year-on-year [2] Other Developments - Wuyi Vision (06651.HK) has successfully completed systematic adaptation and deep optimization of SimOne 4.0 on the Moore Thread MTT S5000 GPU [3] - China Resources Land (03377.HK) issued a total of 1,996,400 new shares due to the conversion of mandatory convertible bonds [3] - Cornerstone Pharmaceuticals-B (02616.HK) received approval from the UK MHRA for a new indication of Sugliucan in the treatment of small cell lung cancer [4] - MIRXES-B (02629.HK) completed the enrollment process for the CADENCE CRC study [5] - Jingrui Holdings (01862.HK) received additional resumption guidance from the Stock Exchange and continues to be suspended [6] Buyback Activities - Xuanwu Cloud (02392.HK) repurchased 4,000 shares at a cost of HKD 6.22778 million, with buyback prices ranging from HKD 1.52 to HKD 1.57 [7] - Geely Automobile (00175.HK) spent HKD 11.263 million to repurchase 659,000 shares, with buyback prices between HKD 16.99 and HKD 17.18 [8] - NetEase Cloud Music (09899.HK) repurchased approximately HKD 14.9977 million worth of 94,500 shares, with buyback prices ranging from HKD 157.2 to HKD 160.9 [9]

Investment Rating - The report maintains a "Recommended" rating for the pharmaceutical industry [5] Core Insights - The underlying logic of the current pharmaceutical industry era is innovation and international expansion, with a focus on innovative drugs and technology innovation [2][3] - The report highlights the strong performance of the CRO market and suggests a dual investment strategy focusing on both "0 to 1" technology innovation and low-position stocks [2][3] - Key investment directions include BD2.0, small nucleic acids, and supply chains, with a recommendation to explore new technology directions such as AI innovative drugs and small nucleic acids [3] Summary by Sections 1. Key Events in the Pharmaceutical Industry During the Spring Festival - The report notes a prosperous start for innovative drug BD transactions, with significant overseas development and registration progress for key products [13][14] - The total amount of BD transactions for innovative drugs in China for 2026 has already exceeded one-third of the total for 2025, indicating a strong upward trend [15] - The revision of the National Essential Medicines List Management Measures is seen as a potential signal for changes in the essential medicines directory [28] 2. Pharmaceutical Market Review and Hotspot Tracking - The pharmaceutical sector's performance was relatively weak, with a weekly decline of 0.81%, ranking 20th among all industries [34][38] - The total trading volume for pharmaceuticals was 401.12 billion yuan, accounting for 3.83% of the total market, which is below the historical average of 7.09% [55] - The report indicates that the industry is currently experiencing a lack of significant catalysts, with a focus on structural opportunities [1] 3. Investment Recommendations - The report recommends focusing on CRO companies such as Tigermed and Baiao Biotechnology, as well as other CXO and upstream companies [32] - For essential medicines, companies like Panlong Pharmaceutical and Guizhou Sanli are highlighted [32] - The report emphasizes the importance of monitoring the "0 to 1" technology innovation track, particularly in AI innovative drugs and small nucleic acids [32]